Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility

• Main Authors: Michele Gringeri (Author), Giulia Mosini (Author), Vera Battini (Author), Gianluca Cammarata (Author), Greta Guarnieri (Author), Carla Carnovale (Author), Emilio Clementi (Author), Sonia Radice (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The first vaccine against SARS-CoV-2 made available in Italy has been BNT162b2, the two-dose mRNA-based vaccine developed by Pfizer-BioNTech. The ASST Fatebenefratelli-Sacco hospital is located in one of the areas most affected by the pandemic, and to date over 2000 healthcare professionals have bee...